HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, G. Articles by Kuo, M. T. Search for Related Content PubMed PubMed Citation Articles by Zhou, G. Articles by Kuo, M. T. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 25, 15387-15394, June 19, 1998

Wild-type p53-mediated Induction of Rat mdr1b Expression by the Anticancer Drug Daunorubicin

From the Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The expression of P-glycoproteins encoded by the mdr gene family is associated with the emergence of the multidrug resistance phenotype in animal cells. mdr expression can be induced by many extracellular stimulants including cytotoxic drugs and chemical carcinogens. However, little is known about the mechanisms involved. Here, we report that the expression of the rat mdr1b can be induced by anticancer drug daunorubicin. Further analysis identified a bona fide p53-binding site spanning from base pairs 199 to 180 (5'-GAACATGTAGAGACATGTCT-3') in the rat mdr1b promoter that is essential for basal and daunorubicin-inducible promoter activities. In addition, our results show that wild-type p53 can up-regulate not only the promoter function but also endogenous expression of the rat mdr1b. To the best of our knowledge, this is the first report showing that a specific p53-binding site is involved in the transcriptional regulation of mdr gene by wild-type p53. Since p53 is a sensor for a wide variety of genotoxic stresses, our finding has broad implications for understanding the mechanisms involved in the inducible expression of mdr gene by anticancer drugs, chemical carcinogens, UV light, and other DNA-damaging agents.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Ziemann, A. Riecke, G. Rudell, E. Oetjen, H. J. Steinfelder, C. Lass, G. F. Kahl, and K. I. Hirsch-Ernst The Role of Prostaglandin E Receptor-Dependent Signaling via cAMP in Mdr1b Gene Activation in Primary Rat Hepatocyte Cultures J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 378 - 386. [Abstract] [Full Text] [PDF]

				J. A. Bush and G. Li Regulation of the Mdr1 isoforms in a p53-deficient mouse model Carcinogenesis, October 1, 2002; 23(10): 1603 - 1607. [Abstract] [Full Text] [PDF]

				A. Senchenkov, D. A. Litvak, and M. C. Cabot Targeting Ceramide Metabolism--a Strategy for Overcoming Drug Resistance J Natl Cancer Inst, March 7, 2001; 93(5): 347 - 357. [Abstract] [Full Text] [PDF]

				C. Ziemann, A. Burkle, G. F. Kahl, and K. I. Hirsch-Ernst Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures Carcinogenesis, March 1, 1999; 20(3): 407 - 414. [Abstract] [Full Text] [PDF]

				L. Deng, Y.-C. Lin-Lee, F.-X. Claret, and M. T. Kuo 2-Acetylaminofluorene Up-regulates Rat mdr1b Expression through Generating Reactive Oxygen Species That Activate NF-kappa B Pathway J. Biol. Chem., January 5, 2001; 276(1): 413 - 420. [Abstract] [Full Text] [PDF]

				M.-C. Mathieu, I. Lapierre, K. Brault, and M. Raymond Aromatic Hydrocarbon Receptor (AhR){middle dot}AhR Nuclear Translocator- and p53-mediated Induction of the Murine Multidrug Resistance mdr1 Gene by 3-Methylcholanthrene and Benzo(a)pyrene in Hepatoma Cells J. Biol. Chem., February 9, 2001; 276(7): 4819 - 4827. [Abstract] [Full Text] [PDF]